What Is Remicade Used For?

Remicade (infliximab) is a medication used to manage moderate to severe Crohn’s disease and ulcerative colitis, as well as conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by calming the overactive inflammation that causes pain, flares, and other bothersome symptoms—helping improve bowel health, reduce joint discomfort, and clear skin plaques.

Given as an IV infusion on a regular schedule, Remicade (infliximab) can bring steadier symptom control and fewer hospital visits. For some joint conditions, it’s often paired with methotrexate. It’s not a cure, and it isn’t the right fit for everyone, which is why safety screenings, infection checks, and regular lab tests are important.

How Does Remicade Work?

Understanding how Remicade works can help you feel more confident about your treatment. Here’s a clear look at what’s happening in your body:

Your Immune System’s “Alarm”

• Tumor necrosis factor alpha (TNF) is a protein that triggers inflammation.
• In healthy people, TNF helps fight infections and heal injuries.
• In autoimmune conditions, TNF can get stuck in the “on” position, causing chronic inflammation.
• This overactive response can lead to joint pain, digestive symptoms, or skin issues.

How Infliximab Helps

• Infliximab is a monoclonal antibody that binds directly to TNF molecules.
• By blocking TNF, it slows down inflammation and allows tissues to heal.
• Think of it like muffling an overactive alarm—your body can calm down without losing essential immune functions.

What to Expect

• Targeted treatment: Unlike older medicines, Remicade focuses on one pathway rather than suppressing your whole immune system.
• Early results: Many people notice improvements within the first few infusions.
• Scheduled dosing: The medicine stays active for several weeks, so infusions are spaced out rather than daily.

Which Conditions Are Treated with Remicade?

Remicade is used to manage several inflammatory and autoimmune conditions where TNF plays a central role. At California Specialty Pharmacy (CSP), an Acelpa Health company, our care teams work closely with patients to provide personalized guidance and support. Each condition responds differently, and your CSP care team will help set treatment goals tailored to your needs.

Rheumatoid arthritis (RA)

Rheumatoid arthritis causes painful swelling in the joints, often starting in the hands and feet. Without treatment, it can lead to permanent joint damage. Infliximab helps slow this damage by reducing inflammation. It’s often combined with methotrexate, which studies show can improve physical function and reduce joint erosion more than either medicine alone. If methotrexate isn’t enough, your provider may recommend adding infliximab.

Psoriatic arthritis (PsA)

PsA affects people with psoriasis, causing joint pain, stiffness, and skin plaques. Remicade can help both joint and skin symptoms, and many patients notice reduced morning stiffness within the first month of treatment.

Crohn’s disease

Crohn’s can affect any part of the digestive tract, causing abdominal pain, diarrhea, fatigue, and sometimes fistulas. Infliximab helps reduce symptoms and promotes healing of the intestinal lining, with many patients achieving remission.

Ulcerative colitis (UC)

UC targets the colon, leading to bloody stools, urgency, and frequent bathroom trips. Remicade helps heal the colon lining and ease symptoms, and some patients who were facing surgery may be able to avoid it.

Ongoing care

Both conditions require regular monitoring with blood work and, for UC, periodic colonoscopies to track progress and keep treatment safe.

What Can You Expect During Infusion?

Knowing what happens during your infusion can help reduce anxiety and make the process feel more manageable. While each appointment may vary slightly, the overall pattern is similar.

Infusion Schedule

The schedule depends on your condition and how your body responds to treatment. Most patients start with three initial doses at weeks 0, 2, and 6. This “loading phase” helps build medicine levels in your bloodstream quickly.

After that, maintenance infusions usually occur every 8 weeks. Some patients may need doses more often if symptoms return sooner. Your provider can adjust timing or dosage based on how you’re doing and your lab results.

Keeping appointments on track is important. Delays or missed infusions can lead to symptom flares or increase the chance of developing antibodies that make the medicine less effective. Each infusion generally takes 2–3 hours, including observation time afterward, so planning ahead helps everything go smoothly.

During the Infusion

When you arrive, a CSP nurse will check your vital signs and ask about any recent symptoms. Make sure to mention signs of infection, like fever or cough, before starting.

Your nurse will place an IV, usually in your arm, and the medicine flows slowly over about 2 hours. This slow pace is intentional and helps reduce the risk of reactions. A nurse will monitor your blood pressure, pulse, and temperature during the infusion.

Most people tolerate the treatment well and use the time to relax, read, or catch up on work. Afterward, you’ll stay for observation (usually 30–60 minutes) to ensure everything is stable.

Side Effects and Safety

Like all medicines, infliximab can cause side effects. Most are mild, but some need immediate attention. Knowing what to watch for helps you stay safe.

Common infusion reactions may include:

• Headache
• Flushing
• Nausea
• Mild itching
• Muscle aches or tiredness

Signs of an allergic reaction during infusion include hives or a rash, chest tightness or pain, and difficulty breathing. Ask for help immediately if you experience any of these symptoms. 

Luckily, mild reactions can often be managed by slowing the infusion or using premedication, such as antihistamines or acetaminophen. After going home, watch for delayed reactions that can occur hours or even days later, including a fever, rash, muscle or joint pain, or unusual fatigue. 

Serious risks involve infections and heart problems:

• Infections: Infliximab lowers part of the immune response, increasing vulnerability to infections such as tuberculosis, fungal infections, bacterial infections, or viral reactivations (like hepatitis B). Report persistent fever, cough, weight loss, or unusual fatigue quickly.
• Heart problems: Patients with moderate to severe heart failure may experience worsened symptoms.
• Cancer risk: There’s a small increased risk of certain cancers, including lymphoma and skin cancers, so regular screenings and skin checks are important.

What Do You Need to Know Before You Start Remicade?

Starting Remicade requires some preparation and testing. Your care team will gather information to make sure the treatment is safe and effective for you.

Testing and Screening

Before your first infusion, you’ll likely have several tests:

• Tuberculosis screening: Usually a skin or blood test. If you’ve been exposed to TB in the past, a chest X-ray may be needed to check for active disease.
• Hepatitis B testing: Infliximab can reactivate dormant hepatitis B, which can cause serious liver problems. If you carry the virus, your provider may prescribe antiviral medicine during treatment.
• Blood work: Checks liver function, blood cell counts, and inflammation markers. These baseline values help your team track your response to treatment.
• Vaccine review: Live vaccines shouldn’t be given while on this medicine, so your team will make sure your vaccinations are up to date.

Medicine Interactions

It’s important your provider knows all the medicines you take, including over-the-counter products and supplements.

• Other biologics: Combining infliximab with other immune-suppressing biologics can raise infection risk without extra benefit. A washout period may be required if you’re switching from another biologic.
• Methotrexate: Often used alongside infliximab for rheumatoid arthritis. This combination is well-studied and helps prevent the body from developing antibodies against infliximab.

Your CSP care team can help you understand your medication plan, coordinate with your healthcare providers, and answer any questions so you feel prepared and supported before starting treatment.

Taking Control of Your Health with Remicade

Understanding what Remicade is used for and how it works can help you make informed choices about your care. This medicine offers real relief for people living with inflammatory conditions like Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and psoriatic arthritis.

While Remicade requires regular monitoring and carries some risks, many patients find it helps restore energy, ease symptoms, and improve day-to-day quality of life. At California Specialty Pharmacy (CSP), our team is ready to support you every step of the way. Get in touch with CSP to start your infusion journey, get answers to questions, and receive personalized guidance for treatment.

Frequently Asked Questions (FAQ): 

What conditions does Remicade treat?

Remicade (infliximab) helps manage several autoimmune and inflammatory conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis (often combined with methotrexate), psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Each condition responds differently, and your healthcare team will tailor your treatment plan to your needs.

Is Remicade a form of chemotherapy?

No. Remicade is a biologic therapy, which means it’s a targeted medicine (a monoclonal antibody) that blocks tumor necrosis factor alpha (TNF) to reduce inflammation. It works differently from traditional cancer chemotherapy and focuses specifically on calming the overactive immune response in autoimmune conditions.

What are the long term side effects of Remicade?

While most people tolerate Remicade well, there are some potential long-term risks. These can include serious infections like tuberculosis or other opportunistic infections, reactivation of hepatitis B, certain cancers such as lymphoma or skin cancers, worsening heart failure, rare conditions affecting nerves, liver, or blood cells, lupus-like reactions, psoriasis-like skin changes, and delayed allergic or infusion reactions. Regular monitoring helps your healthcare team catch and manage any issues early.

Can infliximab cause diarrhea?

Yes. You may sometimes have diarrhea as a side effect, even though Remicade is also used to treat diarrhea caused by inflammatory bowel disease. Any new or severe diarrhea should be checked by your healthcare provider to rule out infection or other causes.

References:

1. European Medicines Agency (EMA), 2026. Remicade (infliximab). [online] Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/remicade [Accessed 23 February 2026].
2. Hopkins Arthritis Center, 2026. Infliximab (Remicade). [online] Available at: https://www.hopkinsarthritis.org/patient-corner/drug-information/infliximab-remicade/ [Accessed 23 February 2026].
3. Mayo Clinic, 2026. Infliximab (intravenous route): Description. [online] Available at: https://www.mayoclinic.org/drugs-supplements/infliximab-intravenous-route/description/drg-20068387 [Accessed 23 February 2026].
4. MedlinePlus, 2026. Tumor necrosis factor inhibitors. [online] Available at: https://medlineplus.gov/ency/article/000821.htm [Accessed 23 February 2026].
5. REMICADE® (infliximab), 2026. Learn about REMICADE® for rheumatoid arthritis. [online] Available at: https://www.remicade.com/rheumatoid-arthritis/learn-about-remicade.html [Accessed 23 February 2026].
6. Cleveland Clinic, 2026. TNF (tumor necrosis factor) inhibitors. [online] Available at: https://my.clevelandclinic.org/health/treatments/tnf-tumor-necrosis-factor-inhibitors [Accessed 23 February 2026].

 

Legal Disclaimer:

The content provided on this blog is for informational purposes only and is not intended to serve as medical advice, diagnosis, or treatment. While we make every effort to provide accurate and up-to-date information, the details shared here should not be considered a substitute for professional medical consultation or advice.

By accessing this blog, you agree to hold harmless the author, publisher, and any associated parties from any claims, liabilities, or damages arising from the use or interpretation of this content.

© 2026 California Specialty Pharmacy, LLC. All rights reserved.